Even in Talks for $50 Million Series B Led by Khosla Ventures at $300 Million Valuation
Indian healthtech startup Even is in early discussions to raise about US$50 million in its Series B round.
The round would be led by existing backer Khosla Ventures with possible participation from Alpha Wave.
Why This Funding Matters for Indian Healthtech
The potential deal values Even at about US$300 million.
Such valuations show growing investor confidence in Indian companies offering integrated healthcare and insurance services.
Global firms like Khosla Ventures continue to spot opportunities in emerging markets where digital health platforms can reach millions quickly.
This interest helps local startups scale faster and expand access to healthcare and insurance services.
Future Outlook for Even and the Broader Sector
Successful completion of the round could support expansion and product development.
It also signals a positive trend for other health-focused ventures seeking similar capital.
Laypeople may eventually benefit through easier access to integrated healthcare and insurance services.
Overall the talks highlight how venture funding fuels innovation that impacts daily lives across Asia.
